SynthesisWorld journal of urology2016

What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?

Souhil Lebdai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.